Evaluation of a New Biocompatible Pressure Equalizing Tube
Primary Purpose
Otitis Media
Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PE tube with Duckbill Valve
Sponsored by
About this trial
This is an interventional prevention trial for Otitis Media focused on measuring middler ear infection
Eligibility Criteria
Inclusion Criteria:
- Male/ female at all age- newborn to adult.
- Non- pregnant woman.
- Diagnose of middle ear infection and plan for surgery procedure
Exclusion Criteria:
- Pregnant woman
- Incompetent adults (i.e. individuals with cognitive impairment)
- Presence of immunodeficiency; cystic fibrosis; sickle cell disease;
- Another major systemic disease
- Congenital malformation of the external, middle, or inner ear
- Sensorineural hearing loss; otoneurologic disease
- History of prior ear surgery such as tympanoplasty, tympanomastoidectomy, or mastoidectomy; cholesteatoma; chronic mastoiditis; intratemporal or intracranial suppurative complications of otitis media
- Use of ototoxic medication (except topical use)
Sites / Locations
- UCIMC
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
PE tube with Duckbill Valve
Arm Description
PE tube with Duckbill Valve
Outcomes
Primary Outcome Measures
Pressure-equalizing tube with Duckbill Valve stop air and water passage during middle ear infection treatment
Secondary Outcome Measures
Full Information
NCT ID
NCT01775709
First Posted
January 14, 2013
Last Updated
October 28, 2022
Sponsor
University of California, Irvine
Collaborators
Beckman Laser Institute University of California Irvine
1. Study Identification
Unique Protocol Identification Number
NCT01775709
Brief Title
Evaluation of a New Biocompatible Pressure Equalizing Tube
Official Title
Evaluation of a New Biocompatible Pressure Equalizing Tube
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Withdrawn
Why Stopped
no participants enrolled
Study Start Date
July 2012 (undefined)
Primary Completion Date
September 2014 (Actual)
Study Completion Date
September 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Irvine
Collaborators
Beckman Laser Institute University of California Irvine
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Otitis media is the most common illness in children and 5% to 10% of their symptom cause by fluids in their middle ear . The OME can cause hearing loss included poor development of speech and poor communication.
The surgical procedure is considered simple and relatively safe, but several complications may occur after Pressure Equalizing tube insertion. The most prevalent complications are otorrhea, biofilm and formation of retraction pockets. Otorrhea occurs in 30% to 83% of children with tube and is mainly due bacterial contamination of the middle ear either from external ear canal or impaired Eustachian tube. Swimming can facilitate the entry of bacteria into the middle ear from the ear canal through the PE tubes, and this assumption is reinforced by the statistically significant association between the rate of otorrhea and the non-utilization of ear plugs in children who swim (from 47% in children who used ear plugs to 56% in those who did not).
Detailed Description
The researcher at Beckman Laser Institute, University of California, Irvine, develops new medical tool device call biocompatible Pressure Equalizing tube which can stop air passage and pressure equalization instantly, and can prevents water into the middle ear cavity. evaluate and compare the efficacy of a biocompatible Pressure Equalizing tube that enables air passage and pressure equalization almost instantly, while prevents the entrance of fluids, specially water, into the middle ear cavity.
The biocompatible Pressure Equalizing tube can reduce the rate of postoperative otorrhea,air passage between outside and middle ear cavity,prevents formation of retraction pockets in TM and swimming with lower risk of otorrhea.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Otitis Media
Keywords
middler ear infection
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PE tube with Duckbill Valve
Arm Type
Experimental
Arm Description
PE tube with Duckbill Valve
Intervention Type
Device
Intervention Name(s)
PE tube with Duckbill Valve
Intervention Description
PE tube with Duckbill Valve
Primary Outcome Measure Information:
Title
Pressure-equalizing tube with Duckbill Valve stop air and water passage during middle ear infection treatment
Time Frame
up to 6 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male/ female at all age- newborn to adult.
Non- pregnant woman.
Diagnose of middle ear infection and plan for surgery procedure
Exclusion Criteria:
Pregnant woman
Incompetent adults (i.e. individuals with cognitive impairment)
Presence of immunodeficiency; cystic fibrosis; sickle cell disease;
Another major systemic disease
Congenital malformation of the external, middle, or inner ear
Sensorineural hearing loss; otoneurologic disease
History of prior ear surgery such as tympanoplasty, tympanomastoidectomy, or mastoidectomy; cholesteatoma; chronic mastoiditis; intratemporal or intracranial suppurative complications of otitis media
Use of ototoxic medication (except topical use)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elliot Botvinick, Ph.D.
Organizational Affiliation
Beckman Laser Institute, UCI
Official's Role
Principal Investigator
Facility Information:
Facility Name
UCIMC
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Evaluation of a New Biocompatible Pressure Equalizing Tube
We'll reach out to this number within 24 hrs